Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma
Clinical trial NCT00967044 · COMPLETED
Trial details
- NCT number
- NCT00967044
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.